Kylonib 200mg Capsule: Effective Relief for Your Condition

Kylonib 200mg Capsule

Description

• Active ingredient: Nilotinib.
• Class: Antineoplastic drug, tyrosine kinase inhibitor.
• Use: Treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML) in adults and pediatric patients, including those newly diagnosed or experiencing side effects from previous treatments like Imatinib.

Contraindications

• Do not take if allergic to Nilotinib or other ingredients.
• Consult doctor if you have heart conditions (heart attack, abnormal electric signal), chest pain, brain stroke, or claudication.
• Inform doctor about liver or pancreas disorders, potassium or magnesium deficiency.
• Avoid grapefruit or grapefruit juice.
• Inform about intolerance to some sugars, as the medicine contains lactose.

Important information during treatment

• Regular blood tests to monitor liver and pancreas function, blood cell counts, heart condition, electrolytes, sugar, and fats.
• Inform doctor if pregnant, planning to get pregnant, or breastfeeding.
• Use effective birth control during treatment.

Therapeutic effects

• Disrupts the signaling route of the BCR-ABL tyrosine kinase protein, inhibiting the growth and spread of cancer cells.

Interaction with other drugs

• Inform healthcare professional about all medicines taken, including prescription, over-the-counter, nutritional supplements, and herbal products.
• Certain medications may reduce effectiveness or cause undesirable side effects.

Storage

• Keep out of sight and reach of children and pets.
• Do not store above 30°C.
• Keep in original packaging to protect from light and moisture.

How to consume

• Take as advised by physician.
• Swallow with a glass of water, do not crush, chew, or open the medicine.
• Dosage and duration determined by doctor based on age, body weight, and disease condition.
• Do not stop taking unless advised by doctor.

Safety advices

• Pregnancy: unsafe to use unless necessary. Consult doctor if pregnant or planning pregnancy.
• Breastfeeding: may be unsafe, consult doctor.
• Lungs: consult doctor if lung conditions exist.
• Liver: use cautiously with liver problems, liver function test before starting treatment.
• Alcohol: unknown safety, consult doctor.
• Driving: unsafe to drive or use machines due to potential side effects like nausea, changes in vision, vomiting.

Side effects

• Serious: sudden weight gain, swelling in hands, feet, ankles, or face, chest pain, blood pressure changes, discoloration of tongue, lips, or skin (blue), abnormal heart rhythm, hair loss, vision problems, stomach pain, vomiting of blood, blood in stools, yellowing of the skin, eyes, and dark urine, high blood sugar levels, sensitivity to light.
• Common: nausea, vomiting, diarrhoea, headache, muscle pain, stomach pain, hair loss, tiredness, constipation, slowing of growth in children, pneumonia, loss of appetite, sleeplessness, depression, anxiety, stomach discomforts like bloating and flatulence after meals, musculoskeletal pain.

FAQs

1. Can Kylonib 200mg cause liver damage? Kylonib 200mg may cause liver function abnormalities, which may indicate liver damage. Regular blood tests are important to monitor liver function.

2. How does Kylonib 200mg differ from other medications used to treat chronic myeloid leukemia, such as Imatinib? Kylonib 200mg is more selective for the BCR-ABL protein and more potent in inhibiting its activity. It is effective in patients who have developed resistance to Imatinib.

3. What are the potential long-term effects of Kylonib 200mg on the body? Potential long-term effects include cardiovascular events, liver dysfunction, pancreatic enzyme elevation, and fluid retention. These side effects are generally rare.

4. How to monitor the effects of Kylonib 200mg over the course of treatment? Monitoring includes regular blood tests, electrocardiograms, and imaging studies.

5. Who should not take Kylonib 200mg? Kylonib 200mg should not be taken by pregnant or breastfeeding women, or by people with severe liver or kidney disease, a history of pancreatitis, or a prolonged QT interval.

Fact box

• Molecule name: Nilotinib.
• Therapeutic class: Antineoplastic drug.
• Pharmacological class: Tyrosine Kinase inhibitors.
• Indications: Blood cancer (Philadelphia chromosome-positive chronic myeloid leukemia) in adults and pediatrics.

Tags: Kylonib, Capsule, 200mg, Medicine, Health, Pharmaceuticals